Skip to main content

Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective?

Publication ,  Journal Article
Zeitler, EP; Chew, DS; Mark, DB
Published in: Circ Cardiovasc Qual Outcomes
November 2023

Duke Scholars

Published In

Circ Cardiovasc Qual Outcomes

DOI

EISSN

1941-7705

Publication Date

November 2023

Volume

16

Issue

11

Start / End Page

e010485

Location

United States

Related Subject Headings

  • Mass Screening
  • Humans
  • Cost-Effectiveness Analysis
  • Cost-Benefit Analysis
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • 4206 Public health
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zeitler, E. P., Chew, D. S., & Mark, D. B. (2023). Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective? Circ Cardiovasc Qual Outcomes, 16(11), e010485. https://doi.org/10.1161/CIRCOUTCOMES.123.010485
Zeitler, Emily P., Derek S. Chew, and Daniel B. Mark. “Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective?Circ Cardiovasc Qual Outcomes 16, no. 11 (November 2023): e010485. https://doi.org/10.1161/CIRCOUTCOMES.123.010485.
Zeitler EP, Chew DS, Mark DB. Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective? Circ Cardiovasc Qual Outcomes. 2023 Nov;16(11):e010485.
Zeitler, Emily P., et al. “Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective?Circ Cardiovasc Qual Outcomes, vol. 16, no. 11, Nov. 2023, p. e010485. Pubmed, doi:10.1161/CIRCOUTCOMES.123.010485.
Zeitler EP, Chew DS, Mark DB. Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective? Circ Cardiovasc Qual Outcomes. 2023 Nov;16(11):e010485.

Published In

Circ Cardiovasc Qual Outcomes

DOI

EISSN

1941-7705

Publication Date

November 2023

Volume

16

Issue

11

Start / End Page

e010485

Location

United States

Related Subject Headings

  • Mass Screening
  • Humans
  • Cost-Effectiveness Analysis
  • Cost-Benefit Analysis
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • 4206 Public health
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology